Micromedic Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ

 
Micromedic today announced that it has identified several new genetic markers with high potential to predict necrosis of the jawbone in patients treated with bisphosphonate drugs, and was able to repeat findings from a previous study for one significant marker in a larger and more diversified group tested in a second trial.


Link to complete article

More News/Information
© Micromedic Technologies Ltd. site mapcontact
 
Site by Site2goal | Design Studio Michal Lehavi